|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
19.43(B) |
Last
Volume: |
1,451,370 |
Avg
Vol: |
1,905,632 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
26,945 |
123,113 |
123,113 |
368,767 |
Total Sell Value |
$2,043,551 |
$8,902,469 |
$8,902,469 |
$27,563,219 |
Total People Sold |
3 |
6 |
6 |
10 |
Total Sell Transactions |
3 |
8 |
8 |
16 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-11-22 |
4 |
S |
$50.09 |
$220,400 |
D/D |
(4,400) |
18,663 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-11-22 |
4 |
OE |
$21.45 |
$94,380 |
D/D |
4,400 |
23,063 |
|
- |
|
Stamoulis Christiana |
Director |
|
2019-11-22 |
4 |
S |
$49.75 |
$612,224 |
D/D |
(12,306) |
37,175 |
|
- |
|
Stamoulis Christiana |
Director |
|
2019-11-22 |
4 |
OE |
$20.01 |
$246,243 |
D/D |
12,306 |
49,481 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-11-12 |
4 |
D |
$46.15 |
$41,212 |
D/D |
(893) |
64,390 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-11-12 |
4 |
D |
$46.15 |
$13,522 |
D/D |
(293) |
18,663 |
|
- |
|
Griffin John M. |
General Counsel |
|
2019-11-12 |
4 |
D |
$46.15 |
$41,443 |
D/D |
(898) |
96,957 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-11-12 |
4 |
D |
$46.15 |
$377,415 |
D/D |
(8,178) |
1,702,717 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2019-11-12 |
4 |
D |
$46.15 |
$39,551 |
D/D |
(857) |
18,178 |
|
- |
|
Bebo Allison P |
SVP, Human Resources |
|
2019-11-12 |
4 |
D |
$46.15 |
$21,367 |
D/D |
(463) |
29,480 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,930 |
65,283 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,872 |
29,401 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,288 |
18,956 |
|
- |
|
Griffin John M. |
General Counsel |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,382 |
97,855 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
101,880 |
1,710,895 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-11-11 |
4 |
OE |
$22.29 |
$4,814,551 |
D/D |
215,996 |
1,609,015 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-11-11 |
4 |
AS |
$45.44 |
$8,924,651 |
D/D |
(194,396) |
1,587,415 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,481 |
19,035 |
|
- |
|
Bebo Allison P |
SVP, Human Resources |
|
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,924 |
29,943 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-09-03 |
4 |
AS |
$49.14 |
$381,621 |
D/D |
(7,766) |
50,353 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-09-03 |
4 |
OE |
$23.82 |
$184,986 |
D/D |
7,766 |
58,119 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-08-05 |
4 |
AS |
$48.41 |
$9,481,029 |
D/D |
(194,396) |
1,587,415 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2019-08-05 |
4 |
OE |
$22.29 |
$4,814,551 |
D/D |
215,996 |
1,781,811 |
|
- |
|
Thornal Kevin R |
Div. President, DiagnosticsOff |
|
2019-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,554 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-06-03 |
4 |
AS |
$44.07 |
$200,298 |
D/D |
(4,545) |
50,353 |
|
- |
|
824 Records found
|
|
Page 13 of 33 |
|
|